GlassScriptPhysician profile
Michael A Antonis
NPI 1619569738
$1,702.67
in general payments reported to CMS, 2019-2025
18 companies · $395 in 2025
The $395 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $174 · 2022: $92.60 · 2023: $792 · 2024: $249 · 2025: $395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,370 · Education: $65.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,370.22 |
| Education | $65.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $387.22 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Bayer Healthcare Pharmaceuticals INC. | $250.00 | 2023-2025 | |
| Astellas Pharma US INC | $185.18 | 2023 | Veozah |
| Atricure, INC. | $156.65 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Silk Road Medical, INC. | $148.80 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Astrazeneca Pharmaceuticals LP | $143.92 | 2021-2025 | Breztri |
| Boston Scientific Corporation | $117.21 | 2023 | Watchman Flx |
| Abbvie INC. | $61.17 | 2021-2024 | |
| Abiomed | $59.86 | 2025 | |
| Novo Nordisk INC | $39.86 | 2022 | |
| Lilly USA, LLC | $28.08 | 2024 | Zepbound, Jardiance, Mounjaro |
| Almatica Pharma LLC | $24.25 | 2023 | Gralise, Loreev Xr |
| Collegium Pharmaceutical, INC. | $22.57 | 2021 | |
| Exact Sciences Corporation | $17.17 | 2024 | Cologuard Collection Kit |
| Acella Pharmaceuticals, LLC | $16.02 | 2024 | NP Thyroid 60 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $15.00 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $14.91 | 2022 | |
| Eisai INC. | $14.80 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Antonis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.